These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 9042392)
1. Isradipine in combination with naltrexone as a medicine for treating cocaine abuse. Reid LD; Pabello NG; Cramer CM; Hubbell CL Life Sci; 1997; 60(8):PL119-26. PubMed ID: 9042392 [TBL] [Abstract][Full Text] [Related]
8. Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans. Sofuoglu M; Singha A; Kosten TR; McCance-Katz FE; Petrakis I; Oliveto A Pharmacol Biochem Behav; 2003 Jul; 75(4):801-8. PubMed ID: 12957222 [TBL] [Abstract][Full Text] [Related]
9. Naltrindole, an opioid delta receptor antagonist, blocks cocaine-induced facilitation of responding for rewarding brain stimulation. Reid LD; Hubbell CL; Glaccum MB; Bilsky EJ; Portoghese PS; Porreca F Life Sci; 1993; 52(9):PL67-71. PubMed ID: 8382329 [TBL] [Abstract][Full Text] [Related]
10. Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhance pressing for rewarding brain stimulation. Reid LD; Hubbell CL; Tsai J; Fishkin MD; Amendola CA Pharmacol Biochem Behav; 1996 Feb; 53(2):477-80. PubMed ID: 8808161 [TBL] [Abstract][Full Text] [Related]
11. Naltrexone maintenance fails to alter amphetamine effects on intracranial self-stimulation in rats. Sakloth F; Negus SS Exp Clin Psychopharmacol; 2018 Apr; 26(2):195-204. PubMed ID: 29528663 [TBL] [Abstract][Full Text] [Related]
12. Effects of repeated-dose isradipine on the abuse liability of cocaine. Roache JD; Johnson BA; Ait-Daoud N; Mauldin JB; Thornton JE; Wells LT; Murff WL Exp Clin Psychopharmacol; 2005 Nov; 13(4):319-26. PubMed ID: 16366762 [TBL] [Abstract][Full Text] [Related]
13. Isradipine and naltrexone in combination with isradipine interact with a period of abstinence to reduce rats' intakes of an alcoholic beverage. Gardell LR; Reid LD; Boedeker KL; Liakos TM; Hubbell CL Alcohol Clin Exp Res; 1997 Dec; 21(9):1592-8. PubMed ID: 9438517 [TBL] [Abstract][Full Text] [Related]
15. Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans. Walsh SL; Sullivan JT; Preston KL; Garner JE; Bigelow GE J Pharmacol Exp Ther; 1996 Nov; 279(2):524-38. PubMed ID: 8930154 [TBL] [Abstract][Full Text] [Related]
16. Effects of naltrexone on amphetamine choice in rhesus monkeys and rats. Robinson HL; Moerke MJ; Banks ML; Negus SS Exp Clin Psychopharmacol; 2023 Dec; 31(6):1080-1091. PubMed ID: 37184942 [TBL] [Abstract][Full Text] [Related]
17. Reinstatement of cocaine-seeking behavior in rats is attenuated following repeated treatment with the opioid receptor antagonist naltrexone. Gerrits MA; Kuzmin AV; van Ree JM Eur Neuropsychopharmacol; 2005 May; 15(3):297-303. PubMed ID: 15820419 [TBL] [Abstract][Full Text] [Related]
18. Role of opioid antagonists in treating intravenous cocaine abuse. Kosten TR; Kleber HD; Morgan C Life Sci; 1989; 44(13):887-92. PubMed ID: 2927249 [TBL] [Abstract][Full Text] [Related]
19. Combination of Levo-Tetrahydropalmatine and Low Dose Naltrexone: A Promising Treatment for Prevention of Cocaine Relapse. Sushchyk S; Xi ZX; Wang JB J Pharmacol Exp Ther; 2016 May; 357(2):248-57. PubMed ID: 26903543 [TBL] [Abstract][Full Text] [Related]
20. Blockade of cocaine-induced conditioned place preference: relevance to cocaine abuse therapeutics. Calcagnetti DJ; Keck BJ; Quatrella LA; Schechter MD Life Sci; 1995; 56(7):475-83. PubMed ID: 7869827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]